Forarite

Forarite is a branded generic combination inhalation therapy developed by Legency Remedies for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It is a fixed-dose combination containing budesonide, an inhaled corticosteroid (ICS), and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA). Budesonide acts as an anti-inflammatory agent that reduces airway swelling and hyperresponsiveness, while formoterol functions as a bronchodilator by relaxing smooth muscle in the airways. Together, these components provide complementary dual action to improve lung function, prevent bronchospasms, and reduce the frequency of asthma and COPD exacerbations.

Brand names

ForariteForarite RCForarite RC 200 RitcapsForarite RC 400 Ritcaps